Search Results - "Luinenburg, Mark"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Epileptogenesis in tuberous sclerosis complex-related developmental and epileptic encephalopathy by Aronica, Eleonora, Specchio, Nicola, Luinenburg, Mark J, Curatolo, Paolo

    Published in Brain (London, England : 1878) (03-07-2023)
    “…Abstract Epileptogenesis in infants with tuberous sclerosis complex (TSC) is a gradual and dynamic process, leading to early onset and difficult-to-treat…”
    Get full text
    Journal Article
  2. 2

    Identification of gene regulatory networks affected across drug-resistant epilepsies by François, Liesbeth, Romagnolo, Alessia, Luinenburg, Mark J., Anink, Jasper J., Godard, Patrice, Rajman, Marek, van Eyll, Jonathan, Mühlebner, Angelika, Skelton, Andrew, Mills, James D., Dedeurwaerdere, Stefanie, Aronica, Eleonora

    Published in Nature communications (11-03-2024)
    “…Epilepsy is a chronic and heterogenous disease characterized by recurrent unprovoked seizures, that are commonly resistant to antiseizure medications. This…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Expression of Oncolytic Adenovirus-Encoded RNAi Molecules Is Most Effective in a pri-miRNA Precursor Format by Brachtlova, Tereza, van Ginkel, Jan-Willem, Luinenburg, Mark J., de Menezes, Renée X., Koppers-Lalic, Danijela, Pegtel, D. Michiel, Dong, Wenliang, de Gruijl, Tanja D., van Beusechem, Victor W.

    Published in Molecular therapy. Oncolytics (16-12-2020)
    “…Oncolytic adenoviruses are being developed as new anti-cancer agents. Their efficacy can be improved by incorporating RNA interference (RNAi) molecules. RNAi…”
    Get full text
    Journal Article
  9. 9

    Genetic pathogenesis of the epileptogenic lesions in Tuberous Sclerosis Complex: Therapeutic targeting of the mTOR pathway by Moavero, Romina, Mühlebner, Angelika, Luinenburg, Mark Jasper, Craiu, Dana, Aronica, Eleonora, Curatolo, Paolo

    Published in Epilepsy & behavior (01-06-2022)
    “…•Overactivation of the mTOR pathway is responsible for TSC-related epilepsy.•Mammalian target of rapamycin (mTOR) inhibitors offer a targeted therapeutic and…”
    Get full text
    Journal Article
  10. 10

    Feasibility of phosphoproteomics to uncover oncogenic signalling in secreted extracellular vesicles using glioblastoma-EGFRVIII cells as a model by Bijnsdorp, Irene V., Schelfhorst, Tim, Luinenburg, Mark, Rolfs, Frank, Piersma, Sander R., de Haas, Richard R., Pham, Thang V., Jimenez, Connie R.

    Published in Journal of proteomics (10-02-2021)
    “…Cancer cells secrete extracellular vesicles (EVs) that contain molecular information, including proteins and RNA. Oncogenic signalling can be transferred via…”
    Get full text
    Journal Article
  11. 11
  12. 12